Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report
A bipartisan group of U.S. lawmakers has reportedly launched national security investigations into Merck & Co. Inc. (NYSE: MRK ) and AbbVie Inc. (NYSE: ABBV ) over concerns that clinical trials conducted in China may have exposed sensitive U.S. biotechnology research to ethical and security risks. The lawmakers are see